P. Yu

RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients

M. Jin, Y. Ge, Zhi-qin Jiang, 2018, Canadian journal of gastroenterology & hepatology.